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Abstract
Rationale—Many of the biochemical, physiological, and behavioral effects of ethanol are known
to be mediated by ionotropic glutamate receptors. Emerging evidence implicates metabotropic
glutamate receptors (mGluRs) in the biobehavioral effects of ethanol and other drugs of abuse, but
there is little information regarding the role of mGluRs in the reinforcing effects of ethanol.
Materials and methods—Male C57BL/6J mice were trained to lever-press on a concurrent fixed
ratio 1 schedule of ethanol (10% v/v) vs water reinforcement during 16-h sessions. Effects of
mGluR1, mGluR2/3, and mGluR5 antagonists were then tested on parameters of ethanol self-
administration behavior.
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Results—The mGluR5 antagonist MPEP (1–10 mg/kg, i.p.) dose-dependently reduced ethanol-
reinforced responding but had no effect on concurrent water-reinforced responding. Analysis of the
temporal pattern of responding showed that MPEP reduced ethanol-reinforced responding during
peak periods of behavior occurring during the early hours of the dark cycle. Further analysis showed
that MPEP reduced the number of ethanol response bouts and bout-response rate. MPEP also
produced a 13-fold delay in ethanol response onset (i.e., latency to the first response) with no
corresponding effect on water response latency or locomotor activity. The mGluR1 antagonist
CPCCOEt (1–10 mg/kg, i.p.) or the mGluR2/3 antagonist LY 341495 (1–30 mg/kg, i.p.) failed to
alter ethanol- or water-reinforced responding.
Conclusions—These data indicate that mGlu5 receptors selectively regulate the onset and
maintenance of ethanol self-administration in a manner that is consistent with reduction in ethanol’s
reinforcement function.
Keywords
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Introduction
Glutamate is the primary excitatory amino acid neurotransmitter in the mammalian central
nervous system. Fast excitatory actions of glutamate are mediated by ionotropic (iGluR) N-
methyl-D-aspartate (NMDA), α-amino-3-hydroxi-5-methyl-ioxyzole-4-propionic acid
(AMPA), and kainate (KA) receptors. Metabotropic glutamate receptors (mGluRs) mediate
slower glutamate responses through G-protein coupling to various intracellular signaling
cascades that can modulate, or fine-tune, iGluR function (Benquet et al. 2002). The eight known
mGluR subtypes have been classified into three groups based on amino acid sequence
similarity, agonist pharmacology, and the signal transduction pathways to which they couple.
Group I mGluRs (mGluR1 and 5) up-regulate Ca2+ cascades, whereas Group II (mGluR2 and
3) and Group III (mGluR4 and 6–8) receptors are negatively coupled to the cyclic adenosine
monophosphate (cAMP) cascade but are distinguished functionally by their differing agonist–
antagonist profiles and sequence homologies (Gereau and Conn 1995; Pin and Duvoisin
1995).
A variety of the physiological, biochemical, and behavioral effects of ethanol are known to
involve iGluR function (Aschner et al. 2001; Costa et al. 2000; Dodd et al. 2000; Littleton et
al. 2001; Mihic 1999; Tabakoff and Hoffman 1993; Weight et al. 1993; Woodward 1999).
Noncompetitive NMDA receptor antagonists substitute for the discriminative stimulus (i.e.,
subjective or cue) effects of ethanol when they are administered systemically (Colombo and
Grant 1992; Grant and Colombo 1993) or in specific limbic brain regions (Hodge and Cox
1998). Accordingly, NMDA receptor antagonists decrease ethanol intake by rats selectively
bred for high ethanol preference (McMillen et al. 2004) and inhibit reinstatement of ethanol-
seeking behavior following extinction (Backstrom and Hyytia 2004). Similarly, the
NMDA2B antagonist ifenprodil reduces relapse-like behavior in rats that have been deprived
of alcohol (Vengeliene et al. 2005).
Emerging evidence implicates mGluR function in ethanol’s neurobehavioral effects. Ethanol
has been shown to reduce both basal and stimulated phosphoinositide hydrolysis (Gonzales et
al. 1986), which indicates modulation of general metabotropic receptor activity by ethanol.
Ethanol alters neuronal firing rates (Netzeband et al. 1997) and Ca2+ levels (Gruol et al.
1997) mediated by mGluRs in vitro. Chronic exposure to ethanol reduces mGluR1 mRNA
levels in cerebellar Purkinje neurons of mice (Simonyi et al. 1996), and early withdrawal from
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ethanol leads to alterations in mGluR-evoked Ca2+ signaling in cerebellar neurons (Netzeband
et al. 2002). Physiologically relevant concentrations of ethanol inhibit glutamate-induced
Ca2+-dependent Cl− currents in Xenopus oocytes expressing mGluR5 but have no effect on
currents in oocytes expressing mGluR1 (Minami et al. 1998), which suggests that ethanol may
selectively alter mGluR5 function. In rats, chronic exposure to an ethanol-containing liquid
diet decreased mRNA levels for mGluR3 and mGluR5 in the dentate gyrus, whereas mGluR1,
mGluR5, and mGluR7 mRNA was decreased in the CA3 regions of the hippocampus (Simonyi
et al. 2004). In addition, recent evidence indicates that the mGluR5 antagonist MPEP decreases
relapse to alcohol self-administration in outbred Long–Evans rats (Backstrom et al. 2004) and
in selectively bred alcohol-preferring P rats (Schroeder et al. 2005) and blocks the
discriminative stimulus effects of ethanol (Besheer and Hodge 2005).
The goal of the present study was to characterize involvement of mGluRs in the reinforcing
effects of ethanol. To accomplish this goal, we trained inbred C57BL/6J mice to self-administer
ethanol on a concurrent fixed ratio 1 (CONC FR1) schedule of ethanol (10% v/v) vs water
reinforcement during 16-h sessions. The effects of mGluR1, mGluR2/3, and mGluR5
antagonists were then assessed on various parameters of self-administration behavior. Results
suggest that full expression of the reinforcing effects of ethanol requires mGlu5 receptor
activity. Preliminary results of this study were presented at the annual meeting of the Research
Society on Alcoholism (Sharko et al. 2002).
Materials and methods
Mice
Male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME, N=32) were housed in
standard Plexiglas cages (17.8×29.2×12.7 cm; W×L×H) with food and water always available.
Mice were 20 weeks of age (body weight, 28–35 g) at the start of testing. Animal housing
rooms were maintained on a 12:12 light–dark cycle (lights on at 0600 hours) at 22°C. All
procedures were approved by the Institutional Animal Care and Use Committee and followed
the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.
Ethanol self-administration
Apparatus—Ethanol self-administration sessions were conducted in eight Plexiglas operant-
conditioning chambers (Med Associates, Georgia, VT) measuring 15.9×14×12.7 cm with
stainless steel grid floors. Each chamber was housed in a sound-attenuating cubicle equipped
with a house fan that provided ventilation and helped mask external noise. The left and right
wall of each operant chamber was equipped with one ultrasensitive stainless steel response
lever and a liquid delivery system. Liquid solutions (ethanol or water) were maintained in 60-
ml syringes mounted on a programmable pump (PHM-100, Med Associates), which delivered
0.01 ml per activation into a stainless steel cup located to the left of the associated response
lever. Each chamber also contained a houselight (illuminated between 1600–1800 hours and
0600–0800 hours) and a stimulus light located above each lever (which was activated each
time the lever was pressed). The operant-conditioning chambers were interfaced (Med
Associates) to an IBM-compatible PC, which was programmed to record all lever presses and
liquid deliveries.
Self-administration procedure—Mice (n=24; 8 per antagonist) were trained to lever-press
using reinforcement (10% sucrose w/v) of successive approximations. After initial response-
shaping sessions, mice were run during 16-h overnight (1600–0800 hours) training sessions.
During these training sessions, both response levers were active on a concurrent fixed ratio 1
(CONC FR1) schedule, with 10% sucrose vs water presented as the reinforcers. The position
of each solution (left or right) was fixed for each animal but counterbalanced between animals
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to control for side preference. After 4 days, mice were trained to orally self-administer ethanol
(10% v/v) vs water using a sucrose substitution procedure (Hodge et al. 1993a; Samson
1986), which we have adapted for use in the mouse (Besheer et al. 2004). Briefly, ethanol (2,
4, 8, or 10% v/v) was incrementally added to the sucrose (10% w/v) solution for 4 days at each
increasing concentration. Afterwards, sucrose (10, 5, or 2% w/v) was incrementally faded out
of the ethanol-containing solution with 4 days at each decreasing concentration. After sucrose-
substitution training, all mice reliably responded on the CONC FR1 schedule of reinforcement
with ethanol (10% v/v) vs water presented as the reinforcers.
After sucrose substitution, baseline behavior was established over a 6-week period, during
which, mice were tested in overnight (16-h) sessions running from 1600–0800 hours as
previously described (Schroeder et al. 2003). Mice were weighed immediately before being
placed in the chambers to quantify and express the ethanol consumed (grams per kilogram)
after each operant session. Sessions were conducted 4 days/week (i.e., Monday–Thursday
evenings). Following each test session, mice were returned to the home cages. The 12-h light–
dark cycle was maintained in the operant-conditioning chambers by regulation of the houselight
(lights off at 1800 hours and lights on at 0600 hours).
Testing drug effects on mouse operant ethanol self-administration—After the 6-
week baseline period, the effects of pre-session administration of mGluR antagonists were
tested on parameters of operant ethanol self-administration. Mice were removed from home
cages at approximately 1545 hours, weighed, administered a test drug, and placed immediately
in the operant-conditioning chambers. Houselights were illuminated immediately, and operant
sessions began. All drugs and doses were administered on Tuesday or Thursday in a
randomized Latin-square manner to control for dose order effects. Control data from
noninjection and vehicle sessions were obtained similarly as part of the randomized sequence.
Each mGluR antagonist was examined in separate groups of mice (n=8 per group).
Locomotor activity
Potential locomotor effects of MPEP were examined in Plexiglas chambers (43 cm2) (Med
Associates). Two sets of 16 pulse-modulated infrared photo beams were placed on opposite
walls at 1-in. centers to record x–y ambulatory movements. Activity chambers were computer-
interfaced (Med Associates) for data sampling at 100-ms resolution. Mice (n=8) were handled
and weighed daily for 1 week before activity testing. Prior to each session, the activity chamber
was wiped clean with 2.5% glacial acetic acid to limit any confounding odors. Saline or MPEP
(10 mg/kg, i.p.) was administered, and mice were placed in the center of the chamber.
Horizontal distance traveled (in centimeters) was recorded as an index of motor function.
Drugs
Ethanol solutions for self-administration were prepared by mixing appropriate volumes of
ethanol (95% v/v) and distilled water. Sucrose (w/v) solutions consisted of granulated cane
sugar dissolved in tap water. Ethanol, sucrose, and water solutions were presented at room
temperature. The mGluR1 selective antagonist 7-(hydroxyimino)cyclopropa[b]chromen-1a-
carboxylate ethyl ester (CPCCOEt), mGluR5 selective antagonist 2-methyl-6-(phenylethynyl)
pyridine (MPEP), and group II selective (mGluR2 and mGluR3) antagonist (2S)-2-amino-2-
[(1S,2S)-2-carboxy-cycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY 341495) were
obtained from Tocris (Ellisville, MO, USA). MPEP was dissolved in physiological saline
(0.9%). CPCCOEt and LY 341495 were suspended in (2-hydroxypropyl)-β-cyclodextrin (20%
w/v, Sigma, St. Louis, MO, USA) in distilled water. Drug and vehicle solutions were
administered to mice in a volume of 0.01 ml/10 g body weight.
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Measures of self-administration were response latency (i.e., time at which the first response
occurred relative to the beginning of the session), the total number of ethanol- and water-
reinforced lever presses, volume of ethanol and water consumed (milliliters), self-
administration bouts, number of lever presses per bout, and rate of lever pressing during each
bout (i.e., number of lever presses per bout divided by length of bout). Response bouts were
defined as previously described by our group (Olive et al. 2000). Briefly, a bout was defined
as self-administration of at least 0.2 g/kg of ethanol, with no two responses occurring more
than 6 min apart. Ethanol intake (grams per kilogram) was estimated using each animal’s daily
body weight and the volume of ethanol consumed. Drug dose effects were analyzed statistically
by repeated-measures analysis of variance (ANOVA) followed by a Tukey’s post hoc multiple
comparisons test using SigmaStat v. 3.0 (SPSS, Chicago, IL, USA). Planned comparisons were
conducted with paired t test where indicated.
Results
Total ethanol-reinforced responding
Systemic administration of the mGluR5 antagonist MPEP produced dose-dependent decreases
in total operant ethanol self-administration by C57Bl/6J mice during the 16-h sessions (Fig.
1a). Two-way repeated-measures ANOVA showed a significant effect of reinforcer condition
[F(1,7)= 5.8, p<0.05], which indicated increased self-administration of ethanol vs water. There
was also an overall significant effect of MPEP dose [F(4,28)=13.7, p<0.001] on total responses.
Planned comparisons (paired t test) showed that MPEP (3 or 10 mg/kg) produced dose-
dependent reductions in responding as compared to vehicle control but had no effect on water-
reinforced responses (MPEP 3 mg/kg, t=4.1, p=0.004; MPEP 10 mg/kg, t=4.2, p=0.002; Fig.
1a). Accordingly, analysis by one-way ANOVA confirmed that MPEP decreased [F(4,28)=7.6,
p<0.001] the dose of self-administered ethanol (grams per kilogram) achieved during the total
16-h session (Fig. 1b). The mGluR1 antagonist CPCCOEt and the mGluR2/3 antagonist LY
341495 were both without effect on total ethanol- or water-reinforced responding or dosage of
ethanol (grams per kilogram) that was self-administered (Table 1).
Temporal pattern of ethanol-reinforced responding
Analysis of the temporal distribution of alcohol self-administration showed that ethanol
responses peaked once during the first half (hours 4–6) and once during the second half (hours
13–14) of the dark cycle under control conditions (Fig. 1c, open circles). Two-way repeated-
measures ANOVA on ethanol response patterns found significant main effects of MPEP Dose
[F(3,21)=11.1, p<0.001] and Hour [F(15,105)=4.3, p<0.001]. In addition, the MPEP
Dose×Hour interaction was statistically significant [F(45,315)=3.2, p<0.001], which suggests
that the effects of MPEP depended on the hour at which responding occurred. Multiple
comparison procedure showed that MPEP (10 mg/kg) significantly decreased ethanol-
reinforced responding during the initial period of the dark cycle (hours 2–6) of the 16-h session
(Fig. 1c, closed circles). The low dose of MPEP (1 mg/kg) significantly decreased ethanol-
reinforced responding only at hour 14 (data not shown). Likewise, MPEP (3 mg/kg)
significantly decreased ethanol-reinforced responding only at hour 13 but produced marginal
reductions at hours 4, 8, and 10, which contributed to the overall reduction in total responding
(data not shown). Water-reinforced responding was not significantly altered by MPEP at any
dose or time point tested (i.e., Fig. 1d), confirming the total session analysis. The mGluR1 or
mGluR2/3 antagonist produced no changes in the temporal pattern of ethanol- or water-
reinforced responding.
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Effects of MPEP on ethanol-reinforced response bouts
Since the primary effects of the mGluR5 antagonist MPEP (10 mg/kg) were observed during
the first 8 h of the session, analysis of response bouts (see “Materials and methods” for the
definition of a bout) was conducted during two temporal epochs (0–8 and 8–16 h). Repeated-
measures ANOVA found a significant effect of MPEP dose [F(4,28)= 6.1, p=0.001] on the
number of ethanol-reinforced response bouts. Although there was no significant effect of time,
the effects of MPEP depended on time, as indicated by the significant Dose × Time interaction
[F(4,28)=2.8, p=0.04]. Multiple comparison procedures (Tukey test) showed that MPEP (10
mg/kg) decreased the number of bouts relative to both no-injection and saline controls only
during the first 8 h of the session (p<0.05, Fig. 2a). This decrease in the number of instances
of ethanol self-administration was not accompanied by a change in bout size (Fig. 2b).
However, MPEP dose-dependently [F(4,28)=5.5, p=0.002] decreased response rate during
bouts. The effect of MPEP depended on time, as indicated by the significant Dose × Time
interaction [F(4,28)=2.7, p=0.048] Tukey tests showed that both the 3- and 10-mg/kg doses of
MPEP significantly decreased response rate relative to control (Fig. 2c).
Onset of ethanol-reinforced responding
The onset of ethanol-reinforced responding (i.e., the latency to the first response) was
selectively (as compared to water) delayed by the mGluR5 antagonist MPEP (Fig. 3).
Statistically significant main effects were observed for MPEP Dose [F(4,28)=8.3, p<0.001]
and Reinforcer (ethanol vs water) [F(1,7)=12.1, p=0.01]. In addition, the Dose × Reinforcer
interaction was significant [F(4,28)= 7.5, p<0.001], indicating that the effects of MPEP Dose
depended on the reinforcement condition. Multiple comparison procedures (Tukey test)
indicated that MPEP (10 mg/kg) significantly increased the latency to the first ethanol-
reinforced response in the absence of any effect on the onset of water-reinforced responding
(Fig. 3). The range of latencies observed after MPEP (10 mg/kg) was 29–489 min, with five
of eight mice showing values greater than the mean of 240.8 min. The mGluR1 antagonist
CPCCOEt and the mGluR2/3 antagonist LY 341495 were both without effect on the latency
to the first ethanol- or water-reinforced response.
Locomotor activity
To determine if reductions in ethanol-reinforced responding were associated with the inhibition
of motor ability, the effects of MPEP (10 mg/kg) were tested on locomotor activity in two
separate experiments. First, mice were administered MPEP (10 mg/kg) and placed in locomotor
activity chambers after a 30-min delay. Distance traveled (in centimeters) during a 1-h test
period decreased as a function of time [F(11,156)= 13.2, p<0.001], indicating normal
spontaneous activity and habituation to the environment. However, MPEP produced no
statistically significant effect on motor activity at any time point (Fig. 4a). Second, mice were
administered MPEP (10 mg/kg) 2 h prior to the onset of the dark cycle and were immediately
placed in locomotor-activity chambers for a 16-h test session, which corresponds with the full
self-administration test sessions. Distance traveled varied as a function of time [F(15,195)
=45.5, p<0.001], again indicating normal spontaneous activity and habituation to the
environment. Although there was no significant effect of MPEP alone, MPEP did produce
time-dependent decreases in locomotor activity, as indicated by a significant Drug × Time
interaction [F(15,195)=1.8, p=0.04]. Post hoc comparisons within each hour showed that
MPEP significantly decreased motor activity during hours 7 and 8 of the 16-h session (Tukey,
p<0.05; Fig. 4a), which did not correspond with the time course of effects on self-administration
behavior.
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The main finding of the present study is that the mGluR5 antagonist MPEP decreased the
reinforcing effects of ethanol in alcohol-preferring inbred C57BL6/J mice. The mGluR1
antagonist CPCCOEt or the mGluR2/3 antagonist LY 341495 were without effect on ethanol-
reinforced responding. These data are consistent with emerging evidence implicating mGluR5
in the general regulation of the reinforcing effects of drugs of abuse. For example, mice lacking
the mGluR5 gene do not self-administer cocaine and show no cocaine-induced increase in
locomotor activity (Chiamulera et al. 2001), which indicates a significant role of mGluR5 in
the behavioral effects of psychomotor stimulants. MPEP dose-dependently reduced nicotine
self-administration in rats (Paterson et al. 2003). Recent evidence also indicates that MPEP
decreases ethanol self-administration and blocks relapse to ethanol self-administration in rats
(Backstrom et al. 2004; Schroeder et al. 2005). Together, these data suggest that mGlu5 receptor
activity is required for the full expression of cocaine, nicotine, and ethanol reinforcement in
both rats and mice, which demonstrates interspecies generality of mGluR5 involvement in
addiction.
Results from the present study also suggest that mGluR5 modulation of ethanol reinforcement
is specific. That is, MPEP decreased ethanol self-administration in the absence of effect on
concurrent water-reinforced responding. This is consistent with MPEP reductions in nicotine
self-administration, with no concomitant effect on food-maintained responding (Markou et al.
2004; Paterson et al. 2003; Tessari et al. 2004) and evidence that mGluR5 null mice respond
for food reinforcement (Chiamulera et al. 2001). This interpretation warrants caution, however,
because ethanol- and water-reinforced response rates were significantly different, which may
reflect differential reinforcement function and sensitivity to mGluR5 modulation. In addition,
mGluR5 antagonists decrease food-reinforced responding (Paterson and Markou 2005; Varty
et al. 2005), and caloric content influences ethanol self-administration by C57BL/6NHsd
(McMillen and Williams 1998) and C57BL/6ByJ (Bachmanov et al. 1996a; Bachmanov et al.
1996b) mice, which suggests that observed effects of MPEP on ethanol self-administration
may have been influenced by the caloric properties of ethanol. That said, MPEP also decreases
ethanol- but not water-reinforced responding in selectively bred alcohol-preferring P rats
(Schroeder et al. 2005), which are considered a valid animal model of alcoholism because their
ethanol intake does not appear to be influenced by taste or caloric factors (Lankford et al.
1991; McMillen 1997). Together, these data suggest that mGluR5 activity selectively regulates
drug and ethanol reinforcement when alternative reinforcers are available but may also play a
more general role in motivation.
In addition to effects on the total number of ethanol reinforced responses, the mGluR5
antagonist MPEP produced specific changes in the temporal distribution of responding that
suggest reduced motivation to self-administer ethanol. First, MPEP (10 mg/kg) produced a 13-
fold delay in the onset of the first ethanol-reinforced response, which is consistent with reduced
motivation to start drinking (Schroeder et al. 2003). Second, ethanol-reinforced responding is
well known to occur in temporally contiguous units called “bouts.” This is observed in primates
(Henningfield and Meisch 1979), rats (Samson et al. 1988), and mice (Olive et al. 2000). In
the present study, MPEP (10 mg/kg) decreased the total number of ethanol-reinforced bouts
and the rate of responding during each bout. Thus, mice engaged in fewer temporally clustered
units of self-administration behavior, and responding during each cluster was slower following
MPEP injection. When taken together with the significant delay in response onset, these data
are consistent with reduced motivation to self-administer ethanol.
However, a number of interpretations other than altered motivation are also plausible. First,
MPEP may have altered ethanol-reinforced responding via nonspecific effects on motor ability.
For the most part, however, locomotor data from the present study argue against this
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interpretation because the mGluR5 antagonist did not alter motor activity during the first 6 h
of a 16-h locomotor session, which is when the compound reduced ethanol self-administration.
A second alternative interpretation is that MPEP may have altered the rewarding effects of
ethanol or produced independent rewarding or aversive effects that decreased ethanol self-
administration. This possibility also appears unlikely because MPEP does not alter ethanol-
induced conditioned place preference (CPP) or produce a CPP or conditioned place aversion
when administered alone (McGeehan and Olive 2003; Popik and Wrobel 2002). Third, a
plausible alternative explanation to altered motivation is that MPEP may have altered the
pharmacological effects of ethanol that underlie its reinforcing function. Research from our
laboratory has shown that MPEP blocks the discriminative (i.e., subjective) stimulus effects
of ethanol (Besheer and Hodge 2005), which are fundamental to addiction liability (Stolerman
1992). Thus, MPEP may have blocked the discriminative stimulus effects of self-administered
ethanol, which could functionally shift the concentration response curve for ethanol
reinforcement to the left and occasion less responding. It would be of significant interest to
determine in future studies if MPEP can alter the discriminative stimulus effects of self-
administered ethanol (e.g., Hodge et al. 2001), which would suggest a highly specific
behavioral mechanism of action.
Data from the present experiment show that mGluR1 or mGluR2/3 antagonists were without
effect on ethanol- or water-reinforced responding. This result is consistent with recent evidence
showing that glutamate activity at mGluR5, but not mGluR1 or mGluR2/3, regulates the
reinforcing effects of ethanol in selectively bred alcohol-preferring P rats (Schroeder et al.
2005), which raises the possibility that mGluR regulation of ethanol reinforcement is specific
to the mGluR5 subtype. However, reduced potency of the mGluR1 antagonist at its receptor
should be considered as an alternative explanation for lack of effect of CPCCOEt. Future
studies employing different antagonists, doses, or agonist compounds may find functional
involvement of mGluR1 or mGluR2/3 receptors in ethanol reinforcement. At the present time,
however, the results of this study suggest both reinforcer and receptor subtype specificity in
the modulation of ethanol reinforcement by mGluR5.
It is of significant interest to consider why the mGluR antagonists showed differential
involvement in ethanol reinforcement. Although group I mGluRs (mGluR1 and mGluR5) are
highly related, these receptors have a distinct pattern of expression in the brain that may
determine functional involvement in ethanol self-administration. MGluR1 receptors show low
expression in most limbic brain regions but are highly expressed in the cerebellum where it
regulates motor coordination (Ichise et al. 2000). MGluR5 (and mGluR2/3) receptors are
almost completely absent in the cerebellum, but are highly expressed in limbic brain regions
such as the nucleus accumbens, cortex, and hippocampus, where mGluR1 receptors are less
abundant (Bordi and Ugolini 1999; Spooren et al. 2001; Tamaru et al. 2001). This differential
mesocorticolimbic distribution pattern suggests differential involvement in ethanol self-
administration. For example, evidence from site-specific infusion studies shows ethanol self-
administration is modulated by the activity of specific brain regions, including the ventral
tegmental area, nucleus accumbens, and frontal cortex (Hodge et al. 1995, 1996a,b, 1997,
1993b, 1994; Rassnick et al. 1992; Samson et al. 1993) that express high levels of mGluR5
and mGluR2/3. Thus, based on expression patterns, it is plausible that mGlu5 receptors might
specifically regulate ethanol reinforcement, but mGluR1 might not.
Given the similar expression patterns of mGlu2/3 and mGlu5 receptors, it does not seem likely
that the differential effect of antagonists at these two receptors can be attributed to brain
regional influence. However, evidence suggests that these receptors may be predominantly
expressed at different cellular locations. For example, mGluR5 immunoreactivity is
predominantly postsynaptic (Paquet and Smith 2003), whereas mGlu2/3 receptors are mostly
presynaptic (Tamaru et al. 2001). Thus, the mGluR5 antagonist may have inhibited primarily
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the postsynaptic effects of glutamate (e.g., O’Leary et al. 2000), which appeared to interfere
with ethanol reinforcement. By contrast, the pharmacological blockade of presynaptic mGlu2/3
receptors increases extracellular glutamate levels (Baker et al. 2002), which did not alter
ethanol reinforcement. Therefore, the actions of glutamate at postsynaptic mGlu5 receptors
appear to be necessary for full expression of ethanol reinforcement. Moreover, it appears
plausible that decreasing synaptic glutamate levels via administration of an mGluR2/3 agonist
might also decrease ethanol reinforcement, which has been shown to decrease reinstatement
of cocaine self-administration (Baptista et al. 2004).
The data from this study suggest that mGluR5 activity is required for the full expression of
ethanol’s reinforcing effects. However, the long time course of MPEP effect on ethanol self-
administration (i.e., up to 6 h postadministration) indicates that the observed behavioral effects
are not correlated with direct pharmacological blockade of the receptor. That is, in vivo
occupancy of mGluR5 by MPEP (10 mg/kg) decreases linearly to control levels after 2 h, with
an approximate half-life of 1 h in C57BL/6J mice (Anderson et al. 2003). This suggests that
MPEP administration may have altered the activity of signaling pathway (s) downstream of
mGluR5 that inhibited ethanol self-administration during the effective period of 3–6 h
postadministration. Indeed, activation of postsynaptic mGluR5 up-regulates phospholipase C
(PLC) activity, which in turn activates the second messenger diacylglycerol (DAG) (Linn
2000; Pellegrini-Giampietro et al. 1996). DAG activates protein kinase C (PKC), which can
increase Ca2+ influx via phosphorylation of ionotropic NMDA receptors (MacDonald et al.
1998), which influence ethanol intake (McMillen et al. 2004). Accordingly, we have shown
that gene deletion of PKCε, which is DAG-sensitive, decreases ethanol self-administration
(Hodge et al. 1999), and that the effects of MPEP on two-bottle ethanol intake are dependent
on PKCε (Olive et al. 2005). Together, these findings suggest that MPEP administration may
produce long-term reductions in alcohol self-administration by changing the function of
mGluR5 coupled signaling pathways.
In conclusion, many studies have focused on iGluR involvement in ethanol’s neurobiological
effects, but the clinical utility of manipulating iGluRs remains illusive due to numerous side
effects associated with their widespread central nervous system (CNS) expression (Kemp and
McKernan 2002). MGluRs are rapidly emerging as important therapeutic targets in numerous
areas of neuropathology (Bordi and Ugolini 1999; Spooren et al. 2001), but few studies have
addressed their involvement in ethanol’s reinforcing effects. The results of this preclinical
study indicate that the mGluR5 antagonist MPEP decreases the reinforcing effects of ethanol
and may therefore have utility in the medical management of alcohol abuse and alcoholism,
insomuch as reduced drinking is a viable therapeutic outcome.
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The mGluR5 antagonist MPEP significantly decreased the reinforcing function of ethanol. a
Total number of ethanol- and water-reinforced responses plotted as a function of MPEP dosage.
Asterisk indicates significantly different from vehicle (veh) control, paired t test planned
comparison (p<0.05). b Ethanol intake (grams per kilogram per 16 h) plotted as a function of
MPEP dosage. Asterisk significantly different from veh control (Tukey test, p<0.05). c Number
of ethanol- or d water-reinforced responses following vehicle or MPEP (10 mg/kg) injection
plotted as a function of time (hours). Shaded areas of the graphs indicate responding during
the light portion of the diurnal cycle, and the unshaded area indicates responding during the
12-h dark phase. Asterisk significantly different from veh at the same time point (Tukey test,
p<0.05). All data are plotted as mean±SEM
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The mGluR5 antagonist MPEP significantly altered parameters of ethanol-reinforced response
bouts. a Total number of ethanol response bouts plotted as a function of MPEP dosage. b Total
number of responses per bout plotted as a function of MPEP dosage. c Response rate
(responses/minute) per bout plotted as a function of MPEP dosage. All data are plotted as mean
±SEM during the first and second 8-h periods of the sessions. Asterisk significantly different
from no-injection (ni) and vehicle (veh) control (Tukey test, p<0.05)
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The mGluR5 antagonist MPEP selectively increased the latency to the first ethanol-reinforced
response. Response latency (minutes) is plotted as a function of MPEP dosage. Data represent
mean±SEM. Asterisk significantly different from no-injection (ni) and vehicle (veh) control;
dagger significantly different from water at the same dose of MPEP (Tukey p<0.05)
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Effects of the mGluR5 antagonist MPEP on spontaneous locomotor activity and habituation.
a Effects of MPEP (10 mg/kg)-administered 3 h prior to a 1-h locomotor test session. b Effects
of MPEP (10 mg/kg) administered immediately prior to a 16-h locomotor test session. Data
represent mean±SEM distance traveled (cm). Asterisk indicates significantly different from
saline at the corresponding time point
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